share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:擬議出售證券
美股sec公告 ·  05/10 10:14
Moomoo AI 已提取核心訊息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 05/10/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $3,214.08, were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement, which was compensation from the issuer. This upcoming transaction follows a significant trading activity by Austin over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $276,005. The notice of the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 05/10/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $3,214.08, were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement, which was compensation from the issuer. This upcoming transaction follows a significant trading activity by Austin over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $276,005. The notice of the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
正如在最近的一份文件中宣佈的那樣,Ginkgo Bioworks Holdings, Inc.高管切·奧斯汀定於2024年10月5日出售3,968股A類股票。這些股票的總市值爲3,214.08美元,最初是在2022年7月10日作爲限制性股票歸屬協議的一部分收購的,該協議是發行人的補償。這筆即將進行的交易是在奧斯汀在過去三個月中進行了大量交易活動之後進行的,共出售了246,016股股票,總收益約爲276,005美元。計劃出售的通知與出售的同一天提交,該交易的計劃已於2023年3月14日獲得通過。
正如在最近的一份文件中宣佈的那樣,Ginkgo Bioworks Holdings, Inc.高管切·奧斯汀定於2024年10月5日出售3,968股A類股票。這些股票的總市值爲3,214.08美元,最初是在2022年7月10日作爲限制性股票歸屬協議的一部分收購的,該協議是發行人的補償。這筆即將進行的交易是在奧斯汀在過去三個月中進行了大量交易活動之後進行的,共出售了246,016股股票,總收益約爲276,005美元。計劃出售的通知與出售的同一天提交,該交易的計劃已於2023年3月14日獲得通過。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息